Fresenius Medical Care AGMEX:FME N 58 EV-to-FCF is 10.87 as of Jul. 03, 2026, which is 43% below its 10-year median of 19.07. GuruFocus rates MEX:FME N with a GF Score™ of 58/100 and a GF Value™ of MXN1,668.99 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 65.02% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Fresenius Medical Care AG's Enterprise Value is MXN415,856 Mil.
Fresenius Medical Care AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN38,273 Mil. Therefore, Fresenius Medical Care AG's EV-to-FCF for today is 10.87.
The historical rank and industry rank for Fresenius Medical Care AG's EV-to-FCF or its related term are showing as below:
MEX:FME N'
s EV-to-FCF Range Over the Past 10 Years
Min: 9.08 Med: 19.07 Max: 46.08
Current: 11.84
During the past 13 years, the highest EV-to-FCF of Fresenius Medical Care AG was 46.08. The lowest was 9.08. And the median was 19.07.
MEX:FME N's EV-to-FCF is ranked better than 65.02% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.73
vs MEX:FME N: 11.84
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fresenius Medical Care AG (MEX:FME N) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fresenius Medical Care AG's PE Ratio (TTM) for today is calculated as:
Fresenius Medical Care AG's share price for today is MXN778.14.
Fresenius Medical Care AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN70.237.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Fresenius Medical Care AG EV-to-FCF Related Terms
Fresenius Medical Care AG EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's EV-to-FCF falls into.
Fresenius Medical Care AG's current Enterprise Value is MXN415,856 Mil.
Fresenius Medical Care AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN38,273 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG (MEX:FME N) has a EV-to-FCF of 10.87 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fresenius Medical Care AG and its competitors. This is 43% below median its historical median of 19.07. Over the past decade, Fresenius Medical Care AG's EV-to-FCF has ranged from 9.08 to 46.08. According to the industry distribution chart, Fresenius Medical Care AG ranks #142 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 35%.
Is Fresenius Medical Care AG's EV-to-FCF too high?
Fresenius Medical Care AG's current EV-to-FCF of 10.87 is 43% below median its 10-year median of 19.07. Over the past 10 years, this metric has ranged from a low of 9.08 to a high of 46.08. The Healthcare Providers & Services industry median EV-to-FCF is 17.73. Fresenius Medical Care AG's value of 10.87 is 38.7% below this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #142 out of 406 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius Medical Care AG has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #142 out of 406 companies for EV-to-FCF. This puts Fresenius Medical Care AG in the upper half of its industry. The industry median EV-to-FCF is 17.73. Fresenius Medical Care AG's value of 10.87 is 38.7% below this benchmark. Historically, Fresenius Medical Care AG's own EV-to-FCF has ranged from 9.08 to 46.08 over the past decade. While the company's 10-year median is 19.07 vs. the industry median of 17.73, Fresenius Medical Care AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.73, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current EV-to-FCF of 10.87 is 38.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current EV-to-FCF is 10.87, which is 43% below median its own 10-year median of 19.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (MEX:FME N) is currently considered Possible Value Trap. The stock's GF Value™ is MXN1,668.99, compared to a current price of MXN778.14 — trading 53.4% below its estimated fair value. The current EV-to-FCF is 10.87, which is 43% below median its 10-year median of 19.07 and 38.7% below the Healthcare Providers & Services industry median of 17.73. Fresenius Medical Care AG's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Fresenius Medical Care AG (MEX:FME N), the current EV-to-FCF is 10.87 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (MEX:FME N) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of MXN778.14 is trading 53.4% below its estimated GF Value™ of MXN1,668.99.
GuruFocus considers Fresenius Medical Care AG to be Possible Value Trap.
Key valuation signals for MEX:FME N:
EV-to-FCF: 10.87 (43% below median its 10-year median of 19.07)
GF Value™: MXN1,668.99 vs. price of MXN778.14 (53.4% below fair value)
Industry Position: 38.7% below the Healthcare Providers & Services median (#142 of 406)
No single metric tells the full story. See the MEX:FME N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
58GF Score
Get the complete analysis for MEX:FME N
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:FME N has been successfully added to your 
